Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05718323
Title Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC (RAISE)
Acronym RAISE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors ETOP IBCSG Partners Foundation
Age Groups: senior | adult
Covered Countries ITA | FRA | ESP

No variant requirements are available.